Search research articles
Contact Us
Filters
Showing results (31-40 of 185) with videos related to
Page
of 19
Sort By:
The Primary Care Companion for CNS Disorders
|
April 18, 2020
Antidepressant Prescribing in England: Patterns and Costs
Adrian H Heald, Mike Stedman, Mark Davies, et al.
International Journal of Clinical Practice
|
June 8, 2018
Reduction of unnecessary N-terminal pro-brain natriuretic peptide (NT-proBNP) tests: A further lesson in demand management
Mark Livingston, Anura Kalansooriya, Andrew Hartland, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 27, 2018
Should we be screening for thyroid dysfunction in patients with type 2 diabetes mellitus?
Rebecca J Ward, Adrian H Heald, Seyi Ogunmekan, et al.
International Journal of Clinical Practice
|
May 8, 2020
A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis
Mike Stedman, Mark Davies, Mark Lunt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 27, 2021
Mortality in 98 type 1 diabetes mellitus and type 2 diabetes mellitus: Foot ulcer location is an independent risk determinant
Heather Schofield, Samantha Haycocks, Adam Robinson, et al.
Respiratory Medicine
|
February 2, 1999
The management of pulmonary tuberculosis in adults notified in Scotland in 1993
A J Simpson, B Watt, S H Heald, et al.
Diabetes
|
May 27, 2003
Low circulating IGF-II concentrations predict weight gain and obesity in humans
Manjinder S Sandhu, J Martin Gibson, Adrian H Heald, et al.
Cardiovascular Endocrinology & Metabolism
|
May 27, 2024
The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy
Juhi K Gupta, Rathi Ravindrarajah, George Tilston, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 20, 2024
Association of Polypharmacy and Burden of Comorbidities on COVID-19 Adverse Outcomes in People with Type 1 or Type 2 Diabetes
Juhi K Gupta, Rathi Ravindrarajah, George Tilston, et al.
Clinical Endocrinology
|
January 9, 2021
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadism
Adrian H Heald, Michael Stedman, Martin Whyte, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 185) with videos related to
Sort By:
Page
of 19
The Primary Care Companion for CNS Disorders
|
April 18, 2020
Antidepressant Prescribing in England: Patterns and Costs
Adrian H Heald, Mike Stedman, Mark Davies, et al.
International Journal of Clinical Practice
|
June 8, 2018
Reduction of unnecessary N-terminal pro-brain natriuretic peptide (NT-proBNP) tests: A further lesson in demand management
Mark Livingston, Anura Kalansooriya, Andrew Hartland, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners
|
January 27, 2018
Should we be screening for thyroid dysfunction in patients with type 2 diabetes mellitus?
Rebecca J Ward, Adrian H Heald, Seyi Ogunmekan, et al.
International Journal of Clinical Practice
|
May 8, 2020
A phased approach to unlocking during the COVID-19 pandemic-Lessons from trend analysis
Mike Stedman, Mark Davies, Mark Lunt, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
March 27, 2021
Mortality in 98 type 1 diabetes mellitus and type 2 diabetes mellitus: Foot ulcer location is an independent risk determinant
Heather Schofield, Samantha Haycocks, Adam Robinson, et al.
Respiratory Medicine
|
February 2, 1999
The management of pulmonary tuberculosis in adults notified in Scotland in 1993
A J Simpson, B Watt, S H Heald, et al.
Diabetes
|
May 27, 2003
Low circulating IGF-II concentrations predict weight gain and obesity in humans
Manjinder S Sandhu, J Martin Gibson, Adrian H Heald, et al.
Cardiovascular Endocrinology & Metabolism
|
May 27, 2024
The association of polypharmacy with COVID-19 outcomes independent of comorbidities in people with type 2 diabetes: implications for the unforeseen consequences of polypharmacy
Juhi K Gupta, Rathi Ravindrarajah, George Tilston, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders
|
December 20, 2024
Association of Polypharmacy and Burden of Comorbidities on COVID-19 Adverse Outcomes in People with Type 1 or Type 2 Diabetes
Juhi K Gupta, Rathi Ravindrarajah, George Tilston, et al.
Clinical Endocrinology
|
January 9, 2021
Lessons learnt from the variation across 6741 family/general practices in England in the use of treatments for hypogonadism
Adrian H Heald, Michael Stedman, Martin Whyte, et al.
Page
of 19